tiprankstipranks
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (HK:2196)
:2196
Hong Kong Market
2196
Shanghai Fosun Pharmaceutical (Group) Co
RESEARCH TOOLSreports
Want to see HK:2196 full AI Analyst Report?

Shanghai Fosun Pharmaceutical (Group) Co (2196) Ratios

5 Followers

Shanghai Fosun Pharmaceutical (Group) Co Ratios

HK:2196's free cash flow for Q1 2026 was ¥0.50. For the 2026 fiscal year, HK:2196's free cash flow was decreased by ¥ and operating cash flow was ¥0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.93 0.93 0.92 1.00 1.06
Quick Ratio
 0.76 0.76 0.73 0.78 0.85
Cash Ratio
 0.36 0.36 0.36 0.41 0.49
Solvency Ratio
 0.09 0.12 0.10 0.09 0.11
Operating Cash Flow Ratio
 0.16 0.14 0.12 0.10 0.13
Short-Term Operating Cash Flow Coverage
 0.24 0.24 0.24 0.23 0.35
Net Current Asset Value
¥ -24.15B¥ -24.40B¥ -23.04B¥ -23.06B¥ -17.78B
Leverage Ratios
Debt-to-Assets Ratio
 0.32 0.31 0.27 0.27 0.28
Debt-to-Equity Ratio
 0.81 0.75 0.67 0.66 0.68
Debt-to-Capital Ratio
 0.45 0.43 0.40 0.40 0.40
Long-Term Debt-to-Capital Ratio
 0.20 0.20 0.18 0.23 0.22
Financial Leverage Ratio
 2.50 2.46 2.49 2.48 2.40
Debt Service Coverage Ratio
 0.19 0.23 0.39 0.45 0.56
Interest Coverage Ratio
 3.31 2.06 2.73 2.50 8.61
Debt to Market Cap
 0.56 0.72 0.82 0.68 0.43
Interest Debt Per Share
 15.59 14.32 12.44 11.79 11.96
Net Debt to EBITDA
 5.14 3.82 2.11 2.20 1.78
Profitability Margins
Gross Profit Margin
49.44%49.88%47.97%47.54%47.28%
EBIT Margin
9.53%6.27%13.64%11.09%12.60%
EBITDA Margin
13.46%15.25%20.95%18.25%17.92%
Operating Profit Margin
9.63%6.27%10.34%7.99%18.88%
Pretax Profit Margin
12.10%12.32%10.15%7.89%10.41%
Net Profit Margin
8.22%8.12%6.74%5.76%8.49%
Continuous Operations Profit Margin
10.37%10.24%8.55%6.99%8.98%
Net Income Per EBT
67.88%65.93%66.44%73.10%81.56%
EBT Per EBIT
125.76%196.42%98.21%98.70%55.14%
Return on Assets (ROA)
2.80%2.73%2.36%2.10%3.48%
Return on Equity (ROE)
7.02%6.74%5.86%5.22%8.37%
Return on Capital Employed (ROCE)
4.83%3.03%5.31%4.15%11.23%
Return on Invested Capital (ROIC)
3.18%2.00%3.62%3.11%8.34%
Return on Tangible Assets
3.78%3.60%3.18%2.80%4.61%
Earnings Yield
5.05%7.07%7.82%5.78%6.48%
Efficiency Ratios
Receivables Turnover
 3.91 4.23 4.35 4.90 5.01
Payables Turnover
 4.63 4.17 3.56 3.53 3.69
Inventory Turnover
 3.55 3.24 2.94 2.88 3.37
Fixed Asset Turnover
 1.74 1.46 1.75 1.86 2.74
Asset Turnover
 0.34 0.34 0.35 0.36 0.41
Working Capital Turnover Ratio
 -16.21 -14.52 -28.06 41.07 28.39
Cash Conversion Cycle
 122.80 111.37 105.36 97.72 82.26
Days of Sales Outstanding
 98.82 86.21 83.81 74.56 72.84
Days of Inventory Outstanding
 107.40 112.68 124.00 126.69 108.42
Days of Payables Outstanding
 83.42 87.52 102.46 103.53 98.99
Operating Cycle
 206.22 198.89 207.82 201.25 181.26
Cash Flow Ratios
Operating Cash Flow Per Share
 2.26 1.97 1.68 1.27 1.62
Free Cash Flow Per Share
 0.58 0.29 0.02 -0.72 -0.64
CapEx Per Share
 1.68 1.68 1.65 1.99 2.26
Free Cash Flow to Operating Cash Flow
 0.26 0.15 0.01 -0.56 -0.40
Dividend Paid and CapEx Coverage Ratio
 1.03 0.82 0.69 0.44 0.51
Capital Expenditure Coverage Ratio
 1.35 1.17 1.02 0.64 0.72
Operating Cash Flow Coverage Ratio
 0.15 0.14 0.14 0.11 0.14
Operating Cash Flow to Sales Ratio
 0.14 0.13 0.11 0.08 0.10
Free Cash Flow Yield
2.13%1.65%0.19%-4.65%-2.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 18.89 14.15 12.79 17.31 15.44
Price-to-Sales (P/S) Ratio
 1.55 1.15 0.86 1.00 1.31
Price-to-Book (P/B) Ratio
 1.34 0.95 0.75 0.90 1.29
Price-to-Free Cash Flow (P/FCF) Ratio
 42.60 60.76 530.62 -21.48 -34.46
Price-to-Operating Cash Flow Ratio
 11.01 8.91 7.92 12.10 13.66
Price-to-Earnings Growth (PEG) Ratio
 0.94 0.74 0.76 -0.46 -0.68
Price-to-Fair Value
 1.34 0.95 0.75 0.90 1.29
Enterprise Value Multiple
 16.24 11.36 6.23 7.66 9.09
Enterprise Value
 94.07B 70.02B 53.61B 57.89B 71.60B
EV to EBITDA
 17.67 11.36 6.23 7.66 9.09
EV to Sales
 2.26 1.73 1.31 1.40 1.63
EV to Free Cash Flow
 66.15 91.55 802.71 -30.11 -42.84
EV to Operating Cash Flow
 16.02 13.43 11.98 16.96 16.98
Tangible Book Value Per Share
 11.84 12.50 11.11 10.59 10.67
Shareholders’ Equity Per Share
 18.62 18.41 17.68 17.04 17.09
Tax and Other Ratios
Effective Tax Rate
 0.14 0.17 0.16 0.11 0.14
Revenue Per Share
 16.04 15.28 15.37 15.44 16.85
Net Income Per Share
 1.32 1.24 1.04 0.89 1.43
Tax Burden
 0.66 0.66 0.66 0.73 0.82
Interest Burden
 1.69 1.96 0.74 0.71 0.83
Research & Development to Revenue
 0.09 0.10 0.09 0.11 0.10
SG&A to Revenue
 0.33 0.17 0.16 0.11 0.02
Stock-Based Compensation to Revenue
 0.00 <0.01 <0.01 <0.01 <0.01
Income Quality
 3.52 1.23 1.27 1.43 1.07
Currency in CNY